Compare TU & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TU | ELAN |
|---|---|---|
| Founded | 1993 | 1954 |
| Country | Canada | United States |
| Employees | 111500 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 12.2B |
| IPO Year | 2000 | 2018 |
| Metric | TU | ELAN |
|---|---|---|
| Price | $8.24 | $22.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $17.63 | ★ $27.89 |
| AVG Volume (30 Days) | ★ 5.2M | 4.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 9.96% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $4.94 | $8.21 |
| Revenue Next Year | $2.76 | $5.31 |
| P/E Ratio | ★ $25.82 | $102.05 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $8.30 | $19.40 |
| 52 Week High | $15.85 | $27.98 |
| Indicator | TU | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 18.36 | 40.37 |
| Support Level | N/A | $21.89 |
| Resistance Level | $10.11 | $22.69 |
| Average True Range (ATR) | 0.19 | 0.67 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 0.00 | 38.03 |
Telus is one of Canada's Big Three telecom service providers, offering wireless and broadband services nationally, but with strongholds in British Columbia and Alberta. The firm serves 10 million postpaid and prepaid wireless customers. It counts nearly 3 million broadband customers across a network footprint that passes more than 4 million homes. The firm operates two additional segments, Telus Health and Telus Digital. Telus Health covers 170 million individuals, offering preventive medicine and virtual care in 200 countries. Telus Digital primarily offers third-party customer support, online content moderation, and data transformation.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.